Immune checkpoint-induced esophagitis: diagnostic challenges and clinical implications

Shriraj Patel; Michael Makar; Rouenne Seeley; Jinhong Li

doi:10.15403/jgld-6143

Immune checkpoint-induced esophagitis: diagnostic challenges and clinical implications

Authors

Shriraj Patel Department of Internal Medicine, Geisinger Medical Center, Danville, PA, USA
Michael Makar Department of Gastroenterology, Geisinger Medical Center, Danville, PA, USA
Rouenne Seeley Department of Gastroenterology, Geisinger Medical Center, Danville, PA, USA
Jinhong Li Department of Pathology, Geisinger Medical Center, Danville, PA, USA

DOI:

https://doi.org/10.15403/jgld-6143

Keywords:

pembrolizumab, immune checkpoint inhibitor, esophagitis, dysphagia

Downloads

Published

2025-09-26

How to Cite

Patel S, Makar M, Seeley R, Li J. Immune checkpoint-induced esophagitis: diagnostic challenges and clinical implications. JGLD [Internet]. 2025 Sep. 26 [cited 2026 Sep. 14];34(3):411-3. Available from: https://jgld.ro/jgld/index.php/jgld/article/view/6143